SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-031392
Filing Date
2022-11-10
Accepted
2022-11-10 16:32:07
Documents
53
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 732796
2 ex31-1.htm EX-31.1 11728
3 ex31-2.htm EX-31.2 11909
4 ex32-1.htm EX-32.1 7966
5 ex32-2.htm EX-32.2 5267
  Complete submission text file 0001493152-22-031392.txt   3428558

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE indp-20220930.xsd EX-101.SCH 28820
7 XBRL CALCULATION FILE indp-20220930_cal.xml EX-101.CAL 45477
8 XBRL DEFINITION FILE indp-20220930_def.xml EX-101.DEF 86565
9 XBRL LABEL FILE indp-20220930_lab.xml EX-101.LAB 261703
10 XBRL PRESENTATION FILE indp-20220930_pre.xml EX-101.PRE 194013
47 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 432232
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 (646) 427-2727
Indaptus Therapeutics, Inc. (Filer) CIK: 0001857044 (see all company filings)

IRS No.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40652 | Film No.: 221377838
SIC: 2834 Pharmaceutical Preparations